Exchange: NASDAQ·Updated 07:51 AM EDT
DSGN logo

DSGN Design Therapeutics Inc

$14.43
$0.68
(4.50%)
Pre-Market
Prev Close $15.11
Reported EarningsAug 3
Mkt Cap$945.61M
Vol58.00

About DSGN

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
49

Neutral Sentiment

How do you feel about DSGN?

Advertisement|Remove ads.